Hair Removal: Intense Pulsed Light Versus Diode Laser

August 20, 2025 updated by: Christiane Pavani, University of Nove de Julho

Hair Removal by Intense Pulsed Light Versus Diode Laser: Randomized Controlled Clinical Trial

The goal of this clinical trial is to compare the effectiveness of two hair removal techniques: Intense Pulsed Light (IPL) and Diode Laser in woman underarm. .

Main Questions:

  • Determine the thread count in a 4cm² quadrant in the central axillary region before each session, 4-6 weeks after the last session and at follow-up 30 weeks after the last session;
  • Measure the thickness of the hair before each session, 4-6 weeks after the last session and at follow-up 6 months after the last session;
  • Compare the level of pain during procedures;
  • Evaluate the volunteer's level of satisfaction after the end of the sessions programmed by the study;
  • Evaluate quality of life and self-image before and after the end of the sessions programmed by the study;
  • Evaluate the maintenance of results 6 months after the last procedure performed.

Researchers will compare IPL and Diode laser to see if hair removal is similar at short and long time course.

The IPL treatment will be applied to one axilla. The 800nm Diode Laser treatment will be applied to the other axilla. Treatment allocation will be randomized for each participant. Participants will undergo monthly sessions for four months, totaling four treatments. Follow-up assessments will occur 30 days and 6 months after the final session.

Study Overview

Status

Terminated

Conditions

Detailed Description

This is a randomized controlled trial of hair removal in axilla for women, being intense pulsed light compared to diode laser.

The session frequency will be once a month for 4 months, totaling 4 treatments. There will be a follow-up at 30 days and 6 months after the end of the treatment.

After the evaluations and photographs, the armpits will be cleaned with 0.5% alcoholic chlorhexidine and will be shaved with a disposable razor blade. Neutral water-based gel will be applied to the region to receive the treatment. Patients will be instructed not to perform any trichotomy procedures in the region during the research period.

The treatment technique will be punctual where the applicator will be kept in full contact with the skin at 90° and moved to the next point after deposition of energy over the entire treatment area until the defined energy is delivered. The applicator tip will be cooled as much as the equipment allows.

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • São Paulo
      • São Paulo, São Paulo, Brazil, 01.504-001
        • Universidade Nove de Julho
      • São Paulo, São Paulo, Brazil
        • Ambulatório Universidade Nove de Julho

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Female patients,
  • aged 18 and older,
  • with a complaint of hair in the axillary region,
  • Fitzpatrick skin phototype I to IV,
  • presenting dark hair

Exclusion Criteria:

  • Patients who have used medications that alter hair production,
  • Patients who have used medications that are photosensitizing,
  • Patients who have used isotretinoin or vitamin A-synthesized acids, antibiotics such as tetracycline,
  • Patients using anticoagulant
  • Patients with vitiligo or epilepsy,
  • Pregnant or lactating individuals,
  • those with active herpes,
  • Patient with history of tumors,
  • Patient with axillary scarring (hyper or hypotrophic),
  • Patient who have used another method of hair removal involving complete hair removal by pulling with a minimum period of 30 days from the date of the initial assessment, or have used another laser hair removal method in the treatment area,
  • Immunocompromised patients,
  • Patients with sun-sensitive skin with inflammation,
  • Individuals with psoriasis,
  • Patients with tattoos on the application site,
  • Patients who have undergone ovary removal or have reached menopause

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intense Pulsed Light
The hair from axilla of one side of the body will be removed with 4 sessions of Intense Pulsed Light
The axilla will be treated with intense pulsed light, being right or left, depending upon randomization.
Other Names:
  • Randomized
The axilla will be treated with diode laser, being right or left, depending upon randomization.
Other Names:
  • Randomized
Experimental: Diode laser
The hair from axilla of one side of the body will be removed with 4 sessions of Diode Laser
The axilla will be treated with intense pulsed light, being right or left, depending upon randomization.
Other Names:
  • Randomized
The axilla will be treated with diode laser, being right or left, depending upon randomization.
Other Names:
  • Randomized

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hair count
Time Frame: before each session (S0,Month1, Month2, Month3), 4-6 weeks after the last session (Month4) and at follow-up 24 weeks after the last session (Month 10).
The counting of the hairs will be performed by observing the visible hairs in the treatment area photographs of the volunteers. In this way, a percentage comparison will be made in relation to the initial number of hairs. The hair count will be conducted in a 4cm² quadrant in the central axillary region.
before each session (S0,Month1, Month2, Month3), 4-6 weeks after the last session (Month4) and at follow-up 24 weeks after the last session (Month 10).
Global Aesthetic Improvement Scale (GAIS)
Time Frame: 4-6 weeks after the last session (Month4) and at follow-up 24 weeks after the last session (Month 10).
The photographs will be evaluated by two independent and blind evaluators, making a comparison between the photos before the procedure (S0) and the final effect of the short-term (S4) and long-term (S5) treatment. The evaluations will be classified according to the percentage of change: no results 0% reduction, bad reduction 0% to 25%, average 25% to 50%, good 50% to 75% and excellent 75%-100%.
4-6 weeks after the last session (Month4) and at follow-up 24 weeks after the last session (Month 10).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hair Thickness
Time Frame: before each session (S0,Month1, Month2, Month3), 4-6 weeks after the last session (Month4) and at follow-up 24 weeks after the last session (Month 10).
Images of the demarcated region will be obtained using a dermatoscope (5 images per region per assessment). The hair thickness will be measured using the Image J software (NIH).
before each session (S0,Month1, Month2, Month3), 4-6 weeks after the last session (Month4) and at follow-up 24 weeks after the last session (Month 10).
Quality of Live
Time Frame: before first session (S0), and at follow-up 24 weeks after the last session (Month 10).
The WHOQOL-bref quality of life questionnaire consists of 26 questions, with responses following a Likert scale (from 1 to 5, with higher scores indicating better quality of life) his questionnaire includes 2 questions that assess overall quality of life, while the remaining questions make up 4 domains (physical, psychological, social relationships, and environment).
before first session (S0), and at follow-up 24 weeks after the last session (Month 10).
Self - Esteem Scale
Time Frame: before first session (S0) and at follow-up 24 weeks after the last session (Month 10).
The Self - Esteem Rosenberg Scale consists of 10 statements related to self-evaluation and self-acceptance. Respondents must indicate their level of agreement or disagreement with each statement on a response scale that typically ranges from "strongly disagree" to "strongly agree." The statements are mostly positive and are used to assess the extent to which a person feels positive or negative about themselves.
before first session (S0) and at follow-up 24 weeks after the last session (Month 10).
Pain Score (Visual Analogue Scale)
Time Frame: before each session (S0,Month1, Month2, Month3), 4-6 weeks after the last session (Month4) and at follow-up 24 weeks after the last session (Month 10).

Immediately after the end of the procedure in each armpit, the patient will respond using the visual analogue scale (VAS) to the sensation of pain perceived during the procedure.

It consists of a straight line, 10 centimeters long, where one end represents the total absence of pain and the other end represents the most intense pain possible. The person experiencing the pain is asked to mark a point on the line that represents the intensity of the pain they are experiencing. The marked point can be measured in centimeters from the end that represents the absence of pain.

before each session (S0,Month1, Month2, Month3), 4-6 weeks after the last session (Month4) and at follow-up 24 weeks after the last session (Month 10).
Satisfaction level Score
Time Frame: At follow-up 24 weeks after the last session (Month 10).
The patient's satisfaction level with the treatment will be assessed through a questionnaire containing five multiple-choice questions. These questions will address the degree of discomfort experienced during the sessions, how many sessions this discomfort persisted, the satisfaction level regarding the achieved results, the perceived percentage improvement in the concern, and, finally, how likely the patient would recommend the undergone treatment to someone with a similar concern. Each response receive 1 up to 5 points, and the total Score varies from 4 to 20, being the highest as the highest the satisfaction.
At follow-up 24 weeks after the last session (Month 10).

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adverse events
Time Frame: before each session (S0,Month1, Month2, Month3), 4-6 weeks after the last session (Month4) and at follow-up 24 weeks after the last session (Month 10).
Adverse effects noted during and after treatments will be recorded
before each session (S0,Month1, Month2, Month3), 4-6 weeks after the last session (Month4) and at follow-up 24 weeks after the last session (Month 10).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Christiane Pavani, PhD, University of Nove de Julho

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 30, 2023

Primary Completion (Actual)

November 30, 2024

Study Completion (Actual)

November 30, 2024

Study Registration Dates

First Submitted

December 11, 2023

First Submitted That Met QC Criteria

December 11, 2023

First Posted (Actual)

December 21, 2023

Study Record Updates

Last Update Posted (Estimated)

August 27, 2025

Last Update Submitted That Met QC Criteria

August 20, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hair Removal

Clinical Trials on Intense Pulsed Light

Subscribe